Clinical Trials Directory

Trials / Completed

CompletedNCT05124899

Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products

Clinical Evaluation of the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products According to the FDA Final Rule: Sunscreen Drug Products (2011)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the 80-Minute Water Resistant SPF of three sunscreen products (ChapStick Active Performance \[CAP\] UnScented, CAP Herbal Mint Flavour and CAP Mountain Berry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).

Detailed description

A single-center, randomized, controlled, intra-individual comparison, evaluator-blind, clinical study to determine the 80-minute water resistant SPF of three sunscreen lip balms. Each participant will evaluate two of the three test products, an SPF standard and no treatment. Study treatments will be randomly assigned to 4 test sites delineated on the skin of the participant's back. The two test products will be applied to their allocated test sites prior to the 80-minute water immersion procedure (four 20-minute water immersion periods, each followed by a 15-minute air-drying period); the SPF standard will be applied to its allocated test site on completion of the final air-drying period. Test sites will be exposed to doses of ultraviolet (UV) radiation and erythemal response evaluated 16-24 hours later. Minimal erythema dose (MED) will be determined for protected and unprotected sites and used to determine the SPF value of each test product.

Conditions

Interventions

TypeNameDescription
DRUGCAP UnScentedSunscreen lip balm.
DRUGCAP Herbal MintSunscreen lip balm.
DRUGCAP Mountain BerrySunscreen lip balm.
DRUGSPF Standard SunscreenSPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)

Timeline

Start date
2021-11-16
Primary completion
2021-12-18
Completion
2021-12-18
First posted
2021-11-18
Last updated
2024-04-26
Results posted
2024-04-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05124899. Inclusion in this directory is not an endorsement.